Innerva Pharmaceuticals
A company that develops a new drug for the treatment of ocular pain associated with dry eye and other diseases of the ocular surface
Innerva Pharmaceuticals has raised €2.3M across 1 funding round from 1 investor, most recently a round in Nov 2022. Based in Barcelona, Spain; active in Healthtech. Data as of 28 Oct 2026.
Barcelona, Spainwww.innervapharma.com ↗
Total raised
€2.3M
€2,300,000
Funding rounds
1
Investors
1
distinct backers
Active since
2022-11
latest 2022-11
Funding by year
EUR raised per yearInnerva Pharmaceuticals — funding by year — interactive chart.
Data table
| Innerva Pharmaceuticals — funding by year | |
|---|---|
| 2022 | €2.3M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-11-02 | Other | €2.3M | Inveready | View deal → |
Investors
1Related news
- Innerva Pharmaceuticals cierra una ronda de €2,3 M.liderada por Invereadywebcapitalriesgo.com · 2022-11
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel
Global coverage: FundingData